These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3104815)

  • 1. Behavioural and electrocortical spectrum power effects of growth hormone releasing factor in rats.
    Nisticò G; De Sarro GB; Bagetta G; Müller EE
    Neuropharmacology; 1987 Jan; 26(1):75-8. PubMed ID: 3104815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioural and electrocortical spectrum power changes after intraventricular injection of patulin in rats.
    De Sarro GB; Donato A; Bagetta G; Pujia A; Nisticò G
    Arch Toxicol Suppl; 1984; 7():420-4. PubMed ID: 6596010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioural and electrocortical changes induced by paraquat after injection in specific areas of the brain of the rat.
    De Gori N; Froio F; Strongoli MC; De Francesco A; Calò M; Nisticò G
    Neuropharmacology; 1988 Feb; 27(2):201-7. PubMed ID: 3352874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that locus coeruleus is the site where clonidine and drugs acting at alpha 1- and alpha 2-adrenoceptors affect sleep and arousal mechanisms.
    De Sarro GB; Ascioti C; Froio F; Libri V; Nisticò G
    Br J Pharmacol; 1987 Apr; 90(4):675-85. PubMed ID: 2884006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and electrocortical effects after intrastriatal cefazolin in rats are antagonized by drugs enhancing GABA-ergic transmission.
    Nistico G; De Sarro GB; Rotiroti D; Naccari F; Calo M; Silvestri R; Pisanti N
    Res Commun Chem Pathol Pharmacol; 1980 Sep; 29(3):445-58. PubMed ID: 6252580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioural and ECoG spectrum power effects after intraventricular injection of drugs altering dopaminergic transmission in rats.
    Bagetta G; Corasaniti MT; Strongoli MC; Sakurada S; Nisticò G
    Neuropharmacology; 1987 Aug; 26(8):1047-52. PubMed ID: 2889160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioural and electrocortical effects after injection of two ornithine decarboxylase inhibitors into several areas of the brain in the rat.
    De Sarro GB; Ascioti C; Audino MG; Libri V; De Sarro A; Nisticò G
    Neuropharmacology; 1989 Nov; 28(11):1245-51. PubMed ID: 2512517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral and electrocortical effects of beta-endorphin after intracerebral infusion in rats.
    Nisticò G; Stephenson JD; Montanini S; Marmo E
    J Med; 1981; 12(6):463-74. PubMed ID: 6274989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesolimbic involvement in the locomotor stimulant action of thyrotropin-releasing hormone (TRH) in rats.
    Miyamoto M; Nagawa Y
    Eur J Pharmacol; 1977 Jul; 44(2):143-52. PubMed ID: 407089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventral tegmental area: site through which dopamine D2-receptor agonists evoke behavioural and electrocortical sleep in rats.
    Bagetta G; De Sarro G; Priolo E; Nisticò G
    Br J Pharmacol; 1988 Nov; 95(3):860-6. PubMed ID: 2974741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioural, electrocortical and spectrum power effects after intraventricular injection of thallium in rats.
    Nisticò G; Faraone V; Pujia A; Persico N; Marmo E
    Zhongguo Yao Li Xue Bao; 1984 Mar; 5(1):1-4. PubMed ID: 6232811
    [No Abstract]   [Full Text] [Related]  

  • 12. Sensitivity of rat forebrain neurons to growth hormone-releasing hormone.
    Twery MJ; Moss RL
    Peptides; 1985; 6(4):609-13. PubMed ID: 3934650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different profile of electrocortical power spectrum changes after micro-infusion into the locus coeruleus of selective agonists at various opioid receptor subtypes in rats.
    Bagetta G; De Sarro GB; Sakurada S; Rispoli V; Nisticò G
    Br J Pharmacol; 1990 Nov; 101(3):655-61. PubMed ID: 1963804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioural and electrocortical power spectrum effects of 5-methoxytryptoline and other analogs after intraventricular administration in rats.
    Nistico G; De Sarro GB; Langer SZ
    Eur J Pharmacol; 1987 Oct; 142(1):121-8. PubMed ID: 3691630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioural and electrocortical changes induced by muscimol in rats withdrawn from chronic treatment with diazepam.
    Bagetta G; Sakurada S; Corasaniti MT; Froio F; Nisticò G
    Neuropharmacology; 1987 Jul; 26(7A):725-30. PubMed ID: 3627381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intraventricular beta-endorphin and D-ALA2-methionine-enkephalinamide on behaviour, spectrum power of electrocortical activity and body temperature in chicks.
    Nisticõ G; Rotiroti D; Naccari F; De Sarro GB; Marmo E
    Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):295-308. PubMed ID: 7394325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of catecholamines and adenosine derivatives given into the brain of fowls.
    Marley E; Nistico G
    Br J Pharmacol; 1972 Dec; 46(4):619-36. PubMed ID: 4347707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition by gastrin-releasing peptide of growth hormone (GH) secretion induced by human pancreatic GH-releasing factor in rats.
    Kabayama Y; Kato Y; Shimatsu A; Ohta H; Yanaihara N; Imura H
    Endocrinology; 1984 Aug; 115(2):649-53. PubMed ID: 6146511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activity in rats.
    Ehlers CL; Reed TK; Henriksen SJ
    Neuroendocrinology; 1986; 42(6):467-74. PubMed ID: 3084988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioural and ECoG spectrum changes induced by intracerebral infusion of interferons and interleukin 2 in rats are antagonized by naloxone.
    De Sarro GB; Masuda Y; Ascioti C; Audino MG; Nistico G
    Neuropharmacology; 1990 Feb; 29(2):167-79. PubMed ID: 1691831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.